View |
|
DR-XY17482
|
Diphenhydramine Hydrochloride
|
Nebrecon
|
12.5 mg/ 5 mL
|
Syrup
|
Antihistamines
|
Lloyd Laboratories,Inc.
|
Philippines
|
Automatic Renewal
|
12 April 2023
|
30 May 2028
|
View |
|
DR-XY17489
|
Cotrimoxazole
|
Bactille TS
|
400mg/ 80mg
|
SUSPENSION
|
Antibacterial
|
Hizon Laboratories, Inc.
|
Philippines
|
Automatic Renewal (E-AR)
|
06 March 2024
|
06 November 2028
|
View |
|
DR-XY17579-B
|
Amoxicillin (as trihydrate)
|
Promox
|
250 mg/5 mL
|
Powder for Suspension
|
Antibacterial (Penicillin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
13 July 2022
|
07 July 2027
|
View |
|
DR-XY17580-B
|
Amoxicillin (As Trihydrate)
|
Promox
|
500 mg
|
Capsule
|
Antibacterial (Penicillin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
01 July 2022
|
03 July 2027
|
View |
|
DR-XY17606
|
Ibuprofen
|
Fevral
|
400 mg
|
Tablet
|
-
|
Scheele lab phils., Inc
|
Philippines
|
-
|
21 February 2020
|
22 January 2025
|
View |
|
DR-XY17607
|
Betamethasone Valerate
|
Steroderm
|
1 mg/g (0.1% w/w)
|
Cream
|
Corticosteroid
|
Ashford Pharmaceutical Laboratories Inc.
|
Philippines
|
-
|
01 December 2020
|
10 August 2025
|
View |
|
DR-XY17609-B
|
Cefalexin (As Monohydrate)
|
Selzef
|
100 mg/mL
|
Powder For Suspension (Oral Drops)
|
Antibacterial (First Generation Cephalosporin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
21 March 2022
|
10 May 2027
|
View |
|
DR-XY17640
|
Minerals
|
Addamel N
|
Formulation: Each ml contains: Chromic Chloride-5.33 mcg-0.02 umol (Cr) Copper Chloride-340 mcg - 2 umol (Cu) Ferric Chloride-540 mcg - 2 umol (Fe) Manganese Chloride-99 mcg-0.5 umol (Mn)Potassium lodide -16.6 mcg-0.1 umol (1)
Sodium Fluoride-210 mcg-5 umol (F) Sodium Molybdate-4.85 mcg - 0.02 umol (Mo) Sodium Selenite, anhydrous -6,9 mcg -0.04 umol (Se) Zinc Chloride-1.36 mg - 10 umol (Zn)
|
Sterile Concentrate Solution for I.V. Infusion
|
-
|
Fresenius Kabi Norge AS
|
Norway
|
-
|
14 January 2021
|
04 January 2026
|
View |
|
DR-XY17641
|
Cefalexin (as Monohydrate)
|
Cefalin
|
100 mg/ mL
|
Powder for Suspension (Oral Drops)
|
Antibacterials
|
Asian Antibiotics, Inc
|
Philippines
|
Automatic Renewal
|
28 February 2022
|
27 February 2027
|
View |
|
DR-XY17642
|
Cefalexin (as Monohydrate)
|
Cefalin
|
250 mg/ 5 mL
|
Powder for Suspension
|
Antibacterial
|
Asian Antibiotics, Inc
|
Philippines
|
Automatic Renewal
|
28 February 2022
|
27 February 2027
|
View |
|
DR-XY17650
|
Allopurinol
|
None
|
100 mg
|
Tablet
|
-
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
-
|
17 December 2021
|
05 June 2026
|
View |
|
DR-XY17652
|
Lamotrigine
|
Lamictal
|
50 mg
|
Tablet
|
Anti-epileptic
|
GlaxoSmithKline Pharmaceuticals
|
Poland
|
Automatic Renewal
|
12 September 2022
|
24 November 2027
|
View |
|
DR-XY17653
|
Lamotrigine
|
Lamictal
|
100mg
|
Tablet
|
Anti-epileptic
|
GlaxoSmithKline Pharmaceuticals S.A.
|
Poland
|
Automatic Renewal
|
30 September 2022
|
24 November 2027
|
View |
|
DR-XY1769
|
Cassia Angustifolia Vahl. (Senna leaves)
|
Kankunis
|
1.5 g
|
Herbal Tea
|
-
|
Taiping Healthbreed of Shantou Co., Ltd.
|
China
|
-
|
04 February 2020
|
16 March 2025
|
View |
|
DR-XY17719-B
|
Cotrimoxazole
|
Cozole
|
400 mg/80 mg
|
Tablet
|
Antibacterial (Sulfonamide)
|
Lloyd Laboratores, Inc.
|
Philippines
|
Automatic Renewal
|
01 September 2022
|
15 October 2027
|
View |
|
DR-XY17727
|
Cefalexin (As Monohydrate)
|
Cidoxine
|
500 mg
|
Capsule
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
15 April 2021
|
10 April 2026
|
View |
|
DR-XY17729
|
AMIKACIN (AS SULFATE)
|
AMIKACIDE
|
125 mg/ mL
|
Solution for Injection (IM/IV)
|
Antibacterial (Aminoglycoside)
|
Amherst Parenterals, Inc.
|
Philippines
|
Renewal
|
28 April 2022
|
08 July 2027
|
View |
|
DR-XY17731
|
Amikacin (as Sulfate)
|
Amikacide
|
250mg/ mL
|
Solution for Injection (IM/IV)
|
Antibacterial (Aminoglycoside)
|
Amherst Parenterals, Inc.
|
Philippines
|
Automatic Renewal
|
28 February 2022
|
13 May 2027
|
View |
|
DR-XY17749
|
Tramadol Hydrochloride
|
TDL
|
50 mg/mL (100 mg/2mL)
|
Solution For Injection
|
Opioid Analgesics
|
Hizon Laboratories, Inc.
|
Philippines
|
Renewal
|
12 February 2019
|
01 April 2029
|
View |
|
DR-XY17752
|
Fentanyl (As Citrate)
|
None
|
100 mcg/2mL (50 mcg/mL)
|
Solution For Injection (Im/Iv)
|
Narcotic-Analgesic
|
Hospira, Inc.
|
U.S.A.
|
Automatic Renewal
|
06 December 2022
|
07 November 2027
|